Claims for Patent: 9,662,342

Summary for Patent: 9,662,342

Title:	Formulations of cyclophosphamide liquid concentrate
Abstract:	Cyclophosphamide containing compositions preferably in the form of solutions having extended stability are disclosed. The compositions contain cyclophosphamide, ethanol and an ethanol soluble acidifying agent such as citric acid. Ready to dilute or ready to use cyclophosphamide containing composition of the invention maintain high levels cyclophosphamide content after about 18 or 24 months at a temperature of about 5.degree. C.
Inventor(s):	Palepu; Nagesh R. (Southampton, PA), Buxton; Philip Christopher (Great Dunmow, GB)
Assignee:	AUROMEDICS PHARMA LLC (East Windsor, NJ)
Application Number:	14/702,320
Patent Claims:	1. A cyclophosphamide containing, substantially non-aqueous liquid composition having extended stability, comprising: a) about 100 to about 600 mg/ml of cyclophosphamide; b) an ethanolic solvent system consisting of ethanol; and c) an ethanol soluble acidifying agent; wherein the cyclophosphamide and the ethanol soluble acidifying agent are solubilized in the ethanol and wherein the cyclophosphamide is the only pharmaceutically active ingredient. 2. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 1, wherein the ethanol soluble acidifying agent is an organic or inorganic acid. 3. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 2, wherein the ethanol-soluble acidifying agent is citric acid or anhydrous citric acid. 4. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 1, wherein concentration of the cyclophosphamide is from about 200 to about 550 mg/ml. 5. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 4, wherein concentration of the cyclophosphamide is about 200 or about 400 mg/ml. 6. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 1, wherein said cyclophosphamide is cyclophosphamide monohydrate. 7. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 3, wherein the citric acid is present in an amount of from about 0.2 to about 2.0% W/V. 8. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 7, wherein the citric acid is present in an amount of from about 0.4 to about 0.8% % W/V. 9. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 8, wherein the citric acid is present in an amount of from about 0.4 to about 0.6% % W/V. 10. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 1, further comprising a source of chloride ions. 11. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 1, further comprising an anti-oxidizing agent. 12. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 11, wherein the anti-oxidizing agent is selected from the group consisting of thioglycerol, propyl gallate, methionine, cysteine and combinations thereof. 13. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 12, wherein the anti-oxidizing agent is thioglycerol. 14. A cyclophosphamide containing, substantially non-aqueous liquid composition according to claim 1, wherein the solution maintains at least about 95% cyclophosphamide content after about 18 months at a temperature of about 5.degree. C. 15. A cyclophosphamide containing, substantially non-aqueous liquid composition according to claim 5, wherein the solution maintains at least about 97% cyclophosphamide content after about 18 months at a temperature of about 5.degree. C. 16. A cyclophosphamide containing, substantially non-aqueous liquid composition, consisting essentially of: a) cyclophosphamide; b) a solvent consisting of ethanol; and c) citric acid; wherein the cyclophosphamide and the citric acid are solubilized in the ethanol and wherein the cyclophosphamide is the only pharmaceutically active ingredient. 17. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 16, wherein the citric acid is anhydrous and the cyclophosphamide is cyclophosphamide monohydrate. 18. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 16, wherein the ratio of cyclophosphamide to citric acid is 50:1. 19. The cyclophosphamide containing, substantially non-aqueous liquid composition of claim 18, wherein the concentration of cyclophosphamide in the composition is either about 200 or about 400 mg/ml.